Skip to search formSkip to main contentSkip to account menu

18F-FPPRGD2

Known as: 18F-FP-PEG3-RGD2, [18F] FPPRGD2, 18F-FP-PRGD2 
A radiopharmaceutical agent comprised of a pegylated dimeric arginine-glycine-aspartic acid (RGD)-based peptide labeled with 2-fluoropropionyl, with… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin
Our previous studies revealed molecular alterations of tumor vessels, varying from immature to mature alterations, resulting from… 
2011
2011
PET imaging of early response to the tyrosine kinase inhibitor ZD4190
PurposeWe evaluated noninvasive positron emission tomography (PET) imaging for monitoring tumor response to the VEGFR-2 tyrosine… 
2011
2011
Abstract 5273: Multiplexed PET probes for imaging breast cancer early response to VEGF121/rGel treatment
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Purpose: Monitoring of tumor early response to therapy… 
2003
2003
Detection of hereditary persistence of alpha-fetoprotein by conformation-sensitive gel electrophoresis analysis.
The concentration of human α-fetoprotein (AFP; MIM 104150) is used as a marker for several diseases in both adults and children… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)